Cargando…
Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer
Background: Toll-like receptor 9 (TLR9) plays a key role in the elimination of viral pathogens by recognising their CpG DNA. Polymorphisms in the TLR9 gene may influence their recognition and subsequent elimination. Therefore, the present study was designed to elucidate the role of a rare unexplored...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171715/ https://www.ncbi.nlm.nih.gov/pubmed/30345020 http://dx.doi.org/10.12688/f1000research.14840.2 |
_version_ | 1783360815344123904 |
---|---|
author | Chauhan, Alex Pandey, Nilesh Raithatha, Nitin Patel, Purvi Desai, Ajesh Jain, Neeraj |
author_facet | Chauhan, Alex Pandey, Nilesh Raithatha, Nitin Patel, Purvi Desai, Ajesh Jain, Neeraj |
author_sort | Chauhan, Alex |
collection | PubMed |
description | Background: Toll-like receptor 9 (TLR9) plays a key role in the elimination of viral pathogens by recognising their CpG DNA. Polymorphisms in the TLR9 gene may influence their recognition and subsequent elimination. Therefore, the present study was designed to elucidate the role of a rare unexplored TLR9 gene polymorphism C296T/ Pro99Leu (rs5743844) in cervical cancer susceptibility among Indian women. Methods: The genotyping of TLR9 Pro99Leu polymorphism in 110 cervical cancer patients and 141 healthy controls was performed by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Results: The genotype frequency detected in both cervical cancer and control populations was 1.0 (CC), 0.0 (CT) and 0.0 (TT); while the allele frequency was found to be 1.0 (C) and 0.0 (T). Conclusions: The present study demonstrates no involvement of TLR9 C296T/ Pro99Leu polymorphism in cervical cancer susceptibility and supports minor allele frequency (MAF) (0.0002) status of the same as no nucleotide variation was detected in any of the study subjects. |
format | Online Article Text |
id | pubmed-6171715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-61717152018-10-19 Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer Chauhan, Alex Pandey, Nilesh Raithatha, Nitin Patel, Purvi Desai, Ajesh Jain, Neeraj F1000Res Research Article Background: Toll-like receptor 9 (TLR9) plays a key role in the elimination of viral pathogens by recognising their CpG DNA. Polymorphisms in the TLR9 gene may influence their recognition and subsequent elimination. Therefore, the present study was designed to elucidate the role of a rare unexplored TLR9 gene polymorphism C296T/ Pro99Leu (rs5743844) in cervical cancer susceptibility among Indian women. Methods: The genotyping of TLR9 Pro99Leu polymorphism in 110 cervical cancer patients and 141 healthy controls was performed by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Results: The genotype frequency detected in both cervical cancer and control populations was 1.0 (CC), 0.0 (CT) and 0.0 (TT); while the allele frequency was found to be 1.0 (C) and 0.0 (T). Conclusions: The present study demonstrates no involvement of TLR9 C296T/ Pro99Leu polymorphism in cervical cancer susceptibility and supports minor allele frequency (MAF) (0.0002) status of the same as no nucleotide variation was detected in any of the study subjects. F1000 Research Limited 2018-08-30 /pmc/articles/PMC6171715/ /pubmed/30345020 http://dx.doi.org/10.12688/f1000research.14840.2 Text en Copyright: © 2018 Chauhan A et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Chauhan, Alex Pandey, Nilesh Raithatha, Nitin Patel, Purvi Desai, Ajesh Jain, Neeraj Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer |
title | Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer |
title_full | Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer |
title_fullStr | Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer |
title_full_unstemmed | Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer |
title_short | Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer |
title_sort | absence of toll-like receptor 9 pro99leu polymorphism in cervical cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171715/ https://www.ncbi.nlm.nih.gov/pubmed/30345020 http://dx.doi.org/10.12688/f1000research.14840.2 |
work_keys_str_mv | AT chauhanalex absenceoftolllikereceptor9pro99leupolymorphismincervicalcancer AT pandeynilesh absenceoftolllikereceptor9pro99leupolymorphismincervicalcancer AT raithathanitin absenceoftolllikereceptor9pro99leupolymorphismincervicalcancer AT patelpurvi absenceoftolllikereceptor9pro99leupolymorphismincervicalcancer AT desaiajesh absenceoftolllikereceptor9pro99leupolymorphismincervicalcancer AT jainneeraj absenceoftolllikereceptor9pro99leupolymorphismincervicalcancer |